Does ALLIENT INC have an economic moat?

Based on its FY2025 SEC filings, the Moat Index scores ALLIENT INC (ALNT) 41.0 out of 100 — a Shallow moat. The four filters behind that score (each 0–100): pricing power 53, returns on capital 23, balance-sheet safety 31, capital discipline 60.

Is ALNT stock trading below its intrinsic value?

Against a deliberately conservative owner-earnings model (9% discount rate, 4% assumed growth, capped at 4%), estimated intrinsic value is $31.22 per share versus a recent price of $87.67 — 181% above value. This is an educational estimate computed from primary SEC filings, not investment advice.

How has ALNT's Moat Score changed over time?

The record logs 3 readings since Jul 17, 2026; the latest reads 41.0 out of 100 (shallow moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.

The Moat Index

ALLIENT INC

ALNT · Healthcare · $1.5B mkt cap · FY2025 filings · Shallow moat ·

Doesn't clear the bar

Shallow moat

The four filters

Pricing power53

Median gross margin 30.2% over 10y, very stable.

Returns on capital23

Median ROIC 7.9%, above the 9% hurdle in 30% of years.

Balance-sheet safety31

Net debt/EBITDA 2.0x, interest coverage 3x.

Capital discipline60

Owner earnings +12.8%/yr, share count growing (dilution).

Margin of safety

Above valueOn sale

181% above value

Owner earnings (normalized): $29.4M
Est. intrinsic value / share: $31.22
Recent price: $87.67
Discount to value: 181% above value

Conservative model: 9% discount rate, 4% assumed growth (capped at 4%), maintenance capex ≈ min(capex, D&A).

17 years of fundamentals

The business, in plain English

ALLIENT INC booked $554.5M of revenue in FY2025 in the Healthcare sector and kept 32.8% of it as gross profit — a moderate-margin business by that measure. After every other cost, 4.0% of each revenue dollar reached the bottom line.

Across the filed record, revenue grew from $80.6M (FY2010) to $554.5M (FY2025) — about 13.7% a year compounded over 15 years.

It earned 7.6% on invested capital in FY2025, with a median of 9.0% across 16 filed years. The Returns on Capital filter above scores it 23/100.

The balance sheet carried $180.4M of total debt in FY2025 against $40.5M of owner earnings — roughly 4.5 years of owner earnings to retire it all. Balance-Sheet Safety scores it 31/100.

The share count rose 108.8% between FY2010 and FY2025 — existing owners have been diluted over the record. Capital Discipline scores it 60/100.

Put together: Capital Discipline is the strongest of the four filters (60/100) and Returns on Capital the weakest (23/100), which is how ALNT lands at 41/100 — a Shallow moat.

This breakdown is generated from the filed numbers and sub-scores above — no outside narrative, no estimates. Where a filing doesn’t disclose an input, the sentence that would need it is omitted instead of guessed.

RevenueSales, as filed$554.5M FY2025

Gross marginRevenue kept after cost of goods32.8% FY2025

Return on invested capitalOperating profit on the capital employed7.6% FY2025

Owner earningsCash an owner could take out$40.5M FY2025

Gaps in a line mean that item isn’t in ALNT’s filings for that year — the series is never interpolated or estimated. The Table view lists every filed value, including operating and net margins, total debt, and share count.

Moat Score history

Moat Score over timeLast scored reading of each day, on the 0–100 scale41.0 / 100

Score history begins Jul 17, 2026 — the record builds from here and can’t be backfilled.

Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars

None yet — ALNT has read Shallow moat for every logged capture since Jul 17, 2026.

Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.

Healthcare context

#224 of 440 scored Healthcare companies, ranked by Moat Score.

Nearest peers by Moat Score

#222IMRX Immuneering Corporation41.3 out of 100, Shallow moatShallow moat
#223STIM NEURONETICS, INC.41.2 out of 100, Shallow moatShallow moat
#225SDEV Stablecoin Development Corporation41.0 out of 100, Shallow moatShallow moat
#226VVOS Vivos Therapeutics, Inc.41.0 out of 100, Shallow moatShallow moat

Compare ALNT with its nearest peers →All Healthcare companies on the Index →

Common questions about ALNT

Does ALLIENT INC have an economic moat?: Based on its FY2025 SEC filings, the Moat Index scores ALLIENT INC (ALNT) 41.0 out of 100 — a Shallow moat. The four filters behind that score (each 0–100): pricing power 53, returns on capital 23, balance-sheet safety 31, capital discipline 60.
Is ALNT stock trading below its intrinsic value?: Against a deliberately conservative owner-earnings model (9% discount rate, 4% assumed growth, capped at 4%), estimated intrinsic value is $31.22 per share versus a recent price of $87.67 — 181% above value. This is an educational estimate computed from primary SEC filings, not investment advice.
How has ALNT's Moat Score changed over time?: The record logs 3 readings since Jul 17, 2026; the latest reads 41.0 out of 100 (shallow moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.

Embed this score on your site

One iframe, no script. The badge shows ALNT’s live Moat Score, updates itself as new filings are scored, and links back here. How it works.

<iframe
  src="https://buylikebuffett.com/embed/ALNT"
  width="340" height="150" style="border:0"
  title="ALNT Moat Score — The Moat Index"
  loading="lazy"></iframe>

Scored from primary SEC filings via the public methodology. Educational only — not a recommendation to buy or sell ALNT. See the disclaimer.